Posted by Michael Wonder on 01 Oct 2016
Breast cancer drug tamoxifen listed on Pharmaceutical Benefits Scheme
1 October 2016 - More Australian women will have access to a preventative breast cancer medicine that has been listed on the Pharmaceutical Benefits Scheme today, the Federal Government says.
The medicine, tamoxifen citrate (Novaldex-D), which had until now been used only as a breast cancer treatment, could cut the risk of getting the disease by 30 to 40%.
Previously, only women who were suffering from a certain type of breast cancer could access this medication on the Pharmaceutical Benefits Scheme.
Federal Health Minister Sussan Ley said that system had now been broadened to include women who were also at a moderate to high risk of getting breast cancer.
